²é¿´: 3042  |  »Ø¸´: 31
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û28´Î£¬×÷ÕßpharmyangÔö¼Ó½ð±Ò 22.2 ¸ö

pharmyang

½ð³æ (ÕýʽдÊÖ)


[×ÊÔ´] ICH Quality Ŀ¼ ºÍËùÓÐÕ½Ú

ÏÂÖÜÃæÊÔÒ»¸ö late stage pharmaceutical development group leader. ÕâÁ½Ìì¿ñ²¹ ICH¡¢GMP¡£Ã»×ö¹ýlate stage£¬ÐÄÀïûµ×°¡¡£
³Ã»ú°ÑÏÂÔØµÄÎļþÕûÀí»ã×ÜÏ£º¸½¼þÒ»ÊÇword°æÄ¿Â¼£»¸½¼þ¶þÊÇword°æµÄ¸÷¸öÕ½ڡ£ £¨±¸×¢£ºÈ«ÊÇÓ¢Îĵģ¬Ã»ÓÐÖÐÎÄ·­Ò룩
Æäʵ¶¼ÊÇ´ÓICHÍøÕ¾ÏÂÔØµÄ£¬´ó¼Ò¿ÉÒÔ×Ô¼ºÈ¥Ï¡£

Stability Q1A - Q1F

        Q1A(R2)Stability Testing of New Drug Substances and Products    Q1A
        Q1BStability Testing : Photostability Testing of New Drug Substances and Products
        Q1CStability Testing for New Dosage Forms
        Q1DBracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products
        Q1EEvaluation of Stability Data
        Q1FStability Data Package for Registration Applications in Climatic Zones III and IV
Analytical Validation Q2

Q2(R1)Validation of Analytical Procedures: Text and Methodology
Impurities Q3A - Q3D
        Q3A(R2)Impurities in New Drug Substances
        Q3B(R2)Impurities in New Drug Products
        Q3C(R5)Impurities: Guideline for Residual Solvents      Q3C, Q3C(M)
        Q3DImpurities: Guideline for Elemental Impurities
        Pharmacopoeias Q4 - Q4B
Code        Document Title        Previously coded
        Q4Pharmacopoeias
        Q4APharmacopoeial Harmonisation
        Q4BEvaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions
        Q4B Annex 1R1Residue on Ignition/Sulphated Ash General Chapter
        Q4B Annex 2R1Test for Extractable Volume of Parenteral Preparations General Chapter
        Q4B Annex 3R1Test for Particulate Contamination: Sub-Visible Particles General Chapter
        Q4B Annex 4AR1Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests General Chapter
        Q4B Annex 4BR1Microbiological Examination of Non-Sterile Products: Tests for Specified Micro-Organisms General Chapter
        Q4B Annex 4CR1Microbiological Examination of Non-Sterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter
        Q4B Annex 5R1Disintegration Test General Chapter
        Q4B Annex 6R1Uniformity of Dosage Units General Chapter
        Q4B Annex 7R2Dissolution Test General Chapter
        Q4B Annex 8R1Sterility Test General Chapter
        Q4B Annex 9R1Tablet Friability General Chapter
        Q4B Annex 10R1Polyacrylamide Gel Electrophoresis General Chapter
        Q4B Annex 11Capillary Electrophoresis General Chapter
        Q4B Annex 12Analytical Sieving General Chapter
        Q4B Annex 13Bulk Density and Tapped Density of Powders General Chapter
        Q4B Annex 14Bacterial Endotoxins Test General Chapter
        Q4B FAQsFrequently Asked Questions
        Quality of Biotechnological Products Q5A - Q5E
Code        Document Title        Previously coded
        Q5A(R1)Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal OriginQ5A
        Q5BAnalysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products
        Q5CStability Testing of Biotechnological/Biological Products
        Q5DDerivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products
        Q5EComparability of Biotechnological/Biological Products Subject to Changes in their Manufacturing Process
        Specifications Q6A- Q6B
Code        Document Title        Previously coded
        Q6ASpecifications : Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances
        Q6BSpecifications : Test Procedures and Acceptance Criteria for Biotechnological/Biological Products
        Good Manufacturing Practice Q7
Code        Document Title        Previously coded
        Q7Good Manufacturing Practice Guide for Active Pharmaceutical IngredientsQ7A
        Q7 Q&AsQuestions and Answers: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
        Pharmaceutical Development Q8
Code        Document Title        Previously coded
        Q8(R2)Pharmaceutical Development
        Q8/9/10 Q&AsR4Q8/Q9/Q10 - Implementation
        Quality Risk Management Q9
Code        Document Title        Previously coded
        Q9Quality Risk Management
        Q8/9/10 Q&AsR4Q8/Q9/Q10 - Implementation
        Pharmaceutical Quality System Q10
Code        Document Title        Previously coded
        Q10Pharmaceutical Quality System
        Q8/9/10 Q&AsR4Q8/Q9/Q10 - Implementation
        Development and Manufacture of Drug Substances Q11
Code        Document Title        Previously coded
        Q11Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities)
        Cross-cutting Topics
Code        Document Title        Previously coded
        Cross-cutting Guidelines
»Ø¸´´ËÂ¥

» ±¾Ìû¸½¼þ×ÊÔ´Áбí

  • »¶Ó­¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
    ±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com
  • ¸½¼þ 1 : A-Contents.docx
  • 2013-11-24 04:44:54, 21.58 K
  • ¸½¼þ 2 : Quality_Guidelines.zip
  • 2013-11-24 04:45:45, 4.68 M

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

Ò©ÎïÉ걨 Êé¼®

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sghio

ľ³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

ѧϰ£¬Ñ§Ï°
2Â¥2013-11-25 10:43:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sghio

ľ³æ (ÕýʽдÊÖ)


ѧϰ£¬Ñ§Ï°
3Â¥2013-11-25 10:43:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

äìÏæâùºì

½ð³æ (СÓÐÃûÆø)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

Â¥Ö÷ÍþÎ䣬һͰ½­ºþ
8Â¥2013-12-26 11:26:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

traveller999

Òø³æ (СÓÐÃûÆø)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

¸Ðл
32Â¥2019-11-20 15:02:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
sghio4Â¥
2013-11-25 10:44   »Ø¸´  
sjshvdc5Â¥
2013-11-26 23:35   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
fenfen1106Â¥
2013-12-13 21:23   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
zhe1997m7Â¥
2013-12-25 12:37   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí
astuxy9Â¥
2013-12-28 17:43   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
Çó½â¶Á10Â¥
2014-03-04 15:40   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wangwenfeng11Â¥
2014-03-21 20:44   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
hch060812Â¥
2014-07-07 15:57   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
28578178813Â¥
2014-07-24 10:22   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
xxfan14Â¥
2014-08-04 14:34   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
researchzzu15Â¥
2014-10-14 11:37   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
758327616Â¥
2015-01-16 14:18   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2015-04-20 20:38   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wendy_8818Â¥
2015-04-29 22:54   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
pumcnsy19Â¥
2015-05-06 09:14   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
±±¸Ú20Â¥
2015-07-23 09:55   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
nangehenha21Â¥
2015-11-26 09:53   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
panjy22Â¥
2015-12-23 15:01   »Ø¸´  
ÎåÐÇºÃÆÀ  ¸Ðл·ÖÏí
wangfst23Â¥
2016-06-15 14:39   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
hdl111424Â¥
2016-07-29 08:38   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
zjwhui25Â¥
2016-07-29 13:21   »Ø¸´  
ÈýÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
aiwen21826Â¥
2016-09-07 12:04   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
jiahan092027Â¥
2016-12-24 09:38   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
jiahan092028Â¥
2016-12-24 09:38   »Ø¸´  
bioliz29Â¥
2017-03-17 16:14   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wind1234hh30Â¥
2017-05-09 15:56   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
lfycdymax31Â¥
2017-05-26 14:03   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ pharmyang µÄÖ÷Ìâ¸üÐÂ
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 khieu8v8m0 2026-02-22 8/400 2026-02-23 09:35 by w4l55oybr1
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 8/400 2026-02-23 09:29 by w4l55oybr1
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +5 usprnugpzw 2026-02-21 11/550 2026-02-23 09:24 by w4l55oybr1
[½Ìʦ֮¼Ò] ΪʲôÖйú´óѧ¹¤¿Æ½ÌÊÚÃÇË®ÁËÄÇô¶àËùνµÄ¶¥»á¶¥¿¯£¬µ«»¹ÊÇ×ö²»³öÓîÊ÷»úÆ÷ÈË£¿ +5 »¶ÀÖËÌÒ¶Ýè 2026-02-21 8/400 2026-02-23 09:19 by »¶ÀÖËÌÒ¶Ýè
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 w89i99eaeh 2026-02-22 5/250 2026-02-23 08:04 by w4l55oybr1
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 6/300 2026-02-23 07:59 by w4l55oybr1
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +6 3dfhjxgsh7 2026-02-22 9/450 2026-02-23 07:49 by w4l55oybr1
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 4/200 2026-02-23 06:46 by jsjzfl
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 khieu8v8m0 2026-02-22 5/250 2026-02-23 06:29 by w4l55oybr1
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 8/400 2026-02-23 06:24 by w4l55oybr1
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +5 3dfhjxgsh7 2026-02-22 6/300 2026-02-23 02:04 by 5jlh3qtdvx
[½Ìʦ֮¼Ò] °æÃæ·Ñ¸Ã½»Âð +7 Æ»¹ûÔÚÄÄÀï 2026-02-22 8/400 2026-02-22 22:37 by otani
[»ù½ðÉêÇë] ÃæÉÏ¿ÉÒÔ³¬¹ý30Ò³°É£¿ +4 °¢À­¹±aragon 2026-02-22 4/200 2026-02-22 21:22 by ɽÎ÷Ðü¿ÕË¿ÕÐüÎ
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 usprnugpzw 2026-02-21 6/300 2026-02-22 19:48 by w89i99eaeh
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 3dfhjxgsh7 2026-02-22 4/200 2026-02-22 16:52 by khieu8v8m0
[ÕÒ¹¤×÷] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 usprnugpzw 2026-02-22 3/150 2026-02-22 16:37 by khieu8v8m0
[»ù½ðÉêÇë] ¡°ÈËÎÄÉç¿Æ¶øÂÛ£¬Ðí¶àѧÊõÑо¿»¹Ã»ÓдﵽÃñ¹úʱÆÚµÄˮƽ¡± +4 ËÕ¶«ÆÂ¶þÊÀ 2026-02-18 5/250 2026-02-22 16:07 by liangep1573
[»ù½ðÉêÇë] ʲôÊÇÈËÒ»Éú×îÖØÒªµÄ£¿ +4 ˲ϢÓîÖæ 2026-02-21 4/200 2026-02-22 11:44 by huagongfeihu
[»ù½ðÉêÇë] ½ñÄê´ºÍíÓм¸¸ö½ÚÄ¿ºÜ²»´í£¬µãÔÞ£¡ +11 ˲ϢÓîÖæ 2026-02-16 12/600 2026-02-21 21:14 by lq493392203
[»ù½ðÉêÇë] ÌåÖÆÄÚ³¤±²ËµÌåÖÆÄÚ¾ø´ó²¿·ÖÒ»±²×ÓÔڵײ㣬ÈçͬÄãÃÇÒ»Ñù´ó²¿·ÖÆÕͨ½ÌʦæÇÒÊÕÈëµÍ +9 ˲ϢÓîÖæ 2026-02-20 12/600 2026-02-21 10:39 by »¶ÀÖËÌÒ¶Ýè
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û